ReviewFrontiers in oncology2024

Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion.

Carmine Pinto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.